Boehringer Ingelheim Pharmaceuticals, Inc.Usage: Synjardy (empagliflozin/metformin) is indicated with diet and exercise to improve blood sugar control in adults and children 10+ with type 2 diabetes. The empagliflozin component also reduces risk of cardiovascular death, heart failure hospitalization, and kidney disease progression in adults with established cardiovascular disease, heart failure, or chronic kidney disease.